Asahara, T, Nomoto, K, Shimizu, K, Watanuki, M & Tanaka, R (2001) Increased resistance of mice to Salmonella enteritica serovar Typhymurium infection by synbiotic administration of bifidobacteria and transgalactosylated-oligosaccharides. J Appl Microbiol 91, 985–996.
Bouhnik, Y, Flourie, B, Ouarne, F, Riottot, M, Bisetti, N, Bornet, F & Rambaud, JC (1994) Effects of prolonged ingestion of fructo-oligosaccharides (FOS) on colonic bifidobacteria, fecal enzymes and bile acids in humans. Gastroenterology 106, A598.
Brück, WB, Kelleher, S, Gibson, GR, Nielsen, KE, Chatterton, DEW & Lönnerdal, B (2003) rRNA probes used to quantify the effects of glycomacropeptide and α-lactalbumin supplementation on the predominant groups of intestinal microflora of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr 37, 273–280.
Buddington, RK, Williams, CH, Chen, S & Witherly, SA (1996) Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 63, 709–716.
Buddington, KK, Danohoo, JB & Buddington, RK (2002) Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumour inducers. J Nutr 132, 472–477.
Crittenden, RG & Playne, MJ (1996) Production, properties and applications of food-grade oligosaccharides. Trends Food Sci Technol 7, 353–361.
Cummings, JH, Christie, S & Cole, TJ (2001) A study of fructooligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther 15, 1139–1145.
Finlay, BB & Falkow, S (1989) Common themes in microbial pathogenicity. Microbiol Rev 53, 210–230.
Gibson, GR & Wang, X (1994a) Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 118, 121–128.
Gibson, GR & Wang, X (1994b) Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77, 412–420.
Gibson, GR & Wang, X (1994c) Bifidogenic properties of different types of fructo-oligosaccharides. Food Microbiol 11, 491–498.
Gibson, GR, Willis, CL & Van Loo, J (1994) Non-digestible oligosaccharides and bifidobacteria – implications for health. Int Sugar J 96, 381–387.
Gibson, GR, Beatty, ER, Wang, X & Cummings, JH (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975–982.
Gibson, GR, Saavedra, JM, Macfarlane, S & Macfarlane, GT (1997) Gastrointestinal microbial disease. Probiotics 2: Application and Practical Aspects, 10 – 39 [Fuller, R, editor]. Andover: Chapman and Hall.
Heerze, LD, Kelm, MA & Talbot, JA (1994) Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhoea and pseudomembranous colitis. J Infect Dis 169, 1291–1296.
Hidaka, H, Eida, T, Takizawa, T, Tokunaga, T & Tashiro, Y (1986) Effects of fructooligosaccharides on intestinal flora and human health. Bifidobacteria Microflora 5, 37–50.
Jayaraman, N, Nepogodiev, SA & Stoddart, JF (1997) Synthetic carbohydrate-containing dendimers. Chem Eur J 3, 1193–1199.
Karlsson, KA (1989) Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem 58, 309–350.
Kleessen, B, Sykura, B, Zunft, H-J & Blaut, M (1997) Effects of inulin and lactose on fecal microflora, microbial activity and bowel habit in elderly constipated persons. Am J Clin Nutr 65, 1397–1402.
McBain, AJ & Macfarlane, GT (1997) Investigations of bifidobacterial ecology and oligosaccharide metabolism in a three-stage compound continuous culture system. Scand J Gastoenterol 32, 32–40.
Meyer, DP, Tungland, BC, Causey, JL & Slavin, JL (2000) The immune effects of inulin in vitro and in vivo. Agro-Food Ind Hi Technol 11, 18–20.
Mitsuoka, T (1990) Bifidobacteria and their role in human health. J Ind Microbiol 6, 263–268.
Mizota, T (1996) Functional and nutritional foods containing bifidogenic factors. Bull Int Dairy Found 313, 31–35.
Oli, MW, Petschow, BW & Buddington, RK (1998) Evaluation of fructooligosaccharide supplementation of oral electrolyte solutions for treatment of diarrhea. Recovery of the intestinal bacteria. Dig Dis Sci 43, 138–147.
Park, SF & Kroll, RG (1993) Expression of listeriolysin and phosphatidylinositol-specific phospholipase C is repressed by the plant-derived molecule cellobiose in Listeria monocytogenes. Mol Microbiol 8, 653–661.
Sghir, A, Chow, JM & Mackie, RI (1998) Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharide as selective substrate. J Appl Microbiol 85, 769–777.
Tuohy, KM, Finlay, RK, Wynne, AG & Gibson, GR (2001) A human volunteer study on the prebiotic effects of HP-Inulin – gut bacteria enumerated using fluorescent in situ hybridisation (FISH). Anaerobe 7, 113–118.
Wang, X & Gibson, GR (1993) Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75, 373–380.
Williams, CH, Witherly, SA & Buddington, RK (1994) Influence of dietary neosugar on selected bacterial groups of the human faecal microbiota. Microb Ecol Health Dis 7, 91–97.